157 related articles for article (PubMed ID: 21294151)
1. Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography-tandem mass spectrometry.
Niessen WM
Mass Spectrom Rev; 2011; 30(4):626-63. PubMed ID: 21294151
[TBL] [Abstract][Full Text] [Related]
2. Fragmentation of toxicologically relevant drugs in negative-ion liquid chromatography-tandem mass spectrometry.
Niessen WM
Mass Spectrom Rev; 2012; 31(6):626-65. PubMed ID: 22829116
[TBL] [Abstract][Full Text] [Related]
3. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
[TBL] [Abstract][Full Text] [Related]
4. An automated screening method for drugs and toxic compounds in human serum and urine using liquid chromatography-tandem mass spectrometry.
Sturm S; Hammann F; Drewe J; Maurer HH; Scholer A
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2726-32. PubMed ID: 20846915
[TBL] [Abstract][Full Text] [Related]
5. Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: systematic investigation using ultra-high-performance liquid chromatography/mass spectrometry with atmospheric-pressure chemical ionization or electrospray ionization.
Remane D; Meyer MR; Wissenbach DK; Maurer HH
Rapid Commun Mass Spectrom; 2010 Nov; 24(21):3103-8. PubMed ID: 20941756
[TBL] [Abstract][Full Text] [Related]
6. Rapid screening and confirmation of drugs and toxic compounds in biological specimens using liquid chromatography/ion trap tandem mass spectrometry and automated library search.
Liu HC; Liu RH; Lin DL; Ho HO
Rapid Commun Mass Spectrom; 2010 Jan; 24(1):75-84. PubMed ID: 19957291
[TBL] [Abstract][Full Text] [Related]
7. LC/MS with a particle beam interface in forensic toxicology.
Spratt E; Vallaro GM
Clin Lab Med; 1998 Dec; 18(4):651-63, viii. PubMed ID: 9891604
[TBL] [Abstract][Full Text] [Related]
8. Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS(E) accurate-mass spectra.
Bijlsma L; Sancho JV; Hernández F; Niessen WM
J Mass Spectrom; 2011 Sep; 46(9):865-75. PubMed ID: 21915950
[TBL] [Abstract][Full Text] [Related]
9. A broad-spectrum equine urine screening method for free and enzyme-hydrolysed conjugated drugs with ultra performance liquid chromatography/tandem mass spectrometry.
Wong CH; Tang FP; Wan TS
Anal Chim Acta; 2011 Jul; 697(1-2):48-60. PubMed ID: 21641418
[TBL] [Abstract][Full Text] [Related]
10. Analysis of OSPAR priority pharmaceuticals using high-performance liquid chromatography-electrospray ionisation tandem mass spectrometry.
Roberts PH; Bersuder P
J Chromatogr A; 2006 Nov; 1134(1-2):143-50. PubMed ID: 16989842
[TBL] [Abstract][Full Text] [Related]
11. Combined use of liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) and high performance liquid chromatography with photodiode array detector (HPLC-DAD) in systematic toxicological analysis.
Broecker S; Pragst F; Bakdash A; Herre S; Tsokos M
Forensic Sci Int; 2011 Oct; 212(1-3):215-26. PubMed ID: 21764531
[TBL] [Abstract][Full Text] [Related]
12. Succinylmonocholine analytics as an example for selectivity problems in high-performance liquid chromatography/tandem mass spectrometry, and resulting implications for analytical toxicology.
Kuepper U; Musshoff F; Madea B
Rapid Commun Mass Spectrom; 2008 Jun; 22(12):1965-70. PubMed ID: 18491286
[TBL] [Abstract][Full Text] [Related]
13. Development of a fast instrumental method for the analysis of pharmaceuticals in environmental and wastewaters based on ultra high performance liquid chromatography (UHPLC)-tandem mass spectrometry (MS/MS).
López-Serna R; Petrović M; Barceló D
Chemosphere; 2011 Nov; 85(8):1390-9. PubMed ID: 21981822
[TBL] [Abstract][Full Text] [Related]
14. Development of an information-rich LC-MS/MS database for the analysis of drugs in postmortem specimens.
Liu HC; Liu RH; Ho HO; Lin DL
Anal Chem; 2009 Nov; 81(21):9002-11. PubMed ID: 19788251
[TBL] [Abstract][Full Text] [Related]
15. Applying 'Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra' (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry.
Arnhard K; Gottschall A; Pitterl F; Oberacher H
Anal Bioanal Chem; 2015 Jan; 407(2):405-14. PubMed ID: 25366975
[TBL] [Abstract][Full Text] [Related]
16. ESI-MS/MS library of 1,253 compounds for application in forensic and clinical toxicology.
Dresen S; Gergov M; Politi L; Halter C; Weinmann W
Anal Bioanal Chem; 2009 Dec; 395(8):2521-6. PubMed ID: 19763548
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
[TBL] [Abstract][Full Text] [Related]
18. Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology.
Maurer HH
Clin Biochem; 2005 Apr; 38(4):310-8. PubMed ID: 15766732
[TBL] [Abstract][Full Text] [Related]
19. Screening for pharmaco-toxicologically relevant compounds in biosamples using high-resolution mass spectrometry: a 'metabolomic' approach to the discrimination between isomers.
Liotta E; Gottardo R; Bertaso A; Polettini A
J Mass Spectrom; 2010 Mar; 45(3):261-71. PubMed ID: 20014151
[TBL] [Abstract][Full Text] [Related]
20. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching.
Gros M; Petrović M; Barceló D
Anal Chem; 2009 Feb; 81(3):898-912. PubMed ID: 19113952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
